Michael Z. Gilcrease
Professor
Pathology
MD Anderson Cancer Center
United States of America
Biography
Degree-Granting Education:- 1991 :Vanderbilt Medical School, Nashville, TN, USA, MD, Medicine 1989 :Vanderbilt Graduate School, Nashville, TN, USA, PHD, Pathology 1984 :Yale College, New Haven, CT, USA, BA, Religious studies. Postgraduate Training:- 1994-1995 :Clinical Fellowship, Surgical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX. 1991-1994 :Clinical Residency, Anatomic Pathology, Baylor College of Medicine, Houston, TX.
Research Interest
Pathology, oncology
Publications
-
Moulder S, Helgason T, Janku F, Wheler J, Moroney J, Booser D, Albarracin C, Morrow PK, Atkins J, Koenig K, Gilcrease M, Kurzrock R. Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer. Ann Oncol 26 (7) :1346-52, 2015.
-
Eghtedari M, Dogan BE, Gilcrease M, Roberts J, Cook ED, Yang WT. Imaging and pathologic characteristics of breast amyloidosis. Breast J 21 (2) :197-9, 2015.
-
Huo L, Gong Y, Guo M, Gilcrease MZ, Wu Y, Zhang H, Zhang J, Resetkova E, Hunt KK, Deavers MT. GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. Histopathology 67 (2) :245-54, 2015.
